Literature DB >> 9344351

Color vision defect type and spatial vision in the optic neuritis treatment trial.

M E Schneck1, G Haegerstrom-Portnoy.   

Abstract

PURPOSE: To describe the types of color vision defects present in the acute phase of the disease and 6 months into recovery in the 438 participants of the Optic Neuritis Treatment Trial.
METHODS: Patients meeting strict eligibility criteria were seen within 8 days of the onset of symptoms and then at regular follow-up visits. At the first and 6-month visits (and subsequent annual visits), spatial vision (acuity, contrast sensitivity), visual fields, and color vision were measured. Farnsworth-Munsell 100-hue tests were scored by a variant of the method of quadrant analysis described by Smith et al (Am J Ophthalmol. 1985; 100:176-182).
RESULTS: Most persons show mixed red-green (RG) and blue-yellow (BY) color defects (one type predominating, accompanied by a lesser defect of the other type). BY defects tend to be slightly more common in the acute phase of the disease, with slightly more RG defects at 6 months. Persons may shift defect type over time. Defect type was not related to any of the spatial vision measures at either test time or to treatment group; however, severity of color defect was related to both spatial vision measures and treatment group.
CONCLUSIONS: Contrary to common clinical wisdom, optic neuritis is not characterized by selective RG defects. Color defect type cannot be used for differential diagnosis of optic neuritis.

Entities:  

Mesh:

Year:  1997        PMID: 9344351

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  25 in total

1.  Outcomes of toll-like receptors' antagonism in steroid-resistant optic neuritis; a pilot study.

Authors:  Aditya Sudhalkar; Mayuri Khamar; Bakulesh Khamar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-12-15       Impact factor: 3.117

2.  Human vision with a lesion of the parvocellular pathway: an optic neuritis model for selective contrast sensitivity deficits with severe loss of midget ganglion cell function.

Authors:  Amal M Al-Hashmi; Daniel J Kramer; Kathy T Mullen
Journal:  Exp Brain Res       Date:  2011-10-18       Impact factor: 1.972

Review 3.  Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis.

Authors:  Madhan Kolappan; Andrew P D Henderson; Thomas M Jenkins; Claudia A M Wheeler-Kingshott; Gordon T Plant; Alan J Thompson; David H Miller
Journal:  J Neurol       Date:  2009-03-18       Impact factor: 4.849

4.  [Multiple sclerosis. An update with practical guidelines for ophthalmologists].

Authors:  T Ziemssen; H Wilhelm; F Ziemssen
Journal:  Ophthalmologe       Date:  2006-07       Impact factor: 1.059

5.  New developments in the treatment of optic neuritis.

Authors:  Thomas M Jenkins; Ahmed T Toosy
Journal:  Eye Brain       Date:  2010-06-17

6.  Comparison between Hardy-Rand-Rittler 4th edition and Ishihara color plate tests for detection of dyschromatopsia in optic neuropathy.

Authors:  Ruth Huna-Baron; Yoseph Glovinsky; Zohar Habot-Wilner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-06-13       Impact factor: 3.117

7.  Outer retinal abnormalities associated with inner retinal pathology in nonglaucomatous and glaucomatous optic neuropathies.

Authors:  J S Werner; J L Keltner; R J Zawadzki; S S Choi
Journal:  Eye (Lond)       Date:  2011-02-04       Impact factor: 3.775

8.  Prospective, cross-sectional study, demonstrating efficacy of blue fixation target while recording Pattern Visual Evoked Potential in optic neuropathy.

Authors:  Ajoy Vincent; Rohit Shetty; Mathew Kurian; Bhujang K Shetty
Journal:  Doc Ophthalmol       Date:  2009-06-10       Impact factor: 2.379

9.  [Investigation of color vision in acute unilateral optic neuritis using a web-based color vision test].

Authors:  J Kuchenbecker; M Blum; F Paul
Journal:  Ophthalmologe       Date:  2016-03       Impact factor: 1.059

10.  Changes in cellular structures revealed by ultra-high resolution retinal imaging in optic neuropathies.

Authors:  Stacey S Choi; Robert J Zawadzki; John L Keltner; John S Werner
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.